152 related articles for article (PubMed ID: 37386813)
1. Integrated analysis identifies RAC3 as an immune-related prognostic biomarker associated with chemotherapy sensitivity in endometrial cancer.
Huang P; Qian Y; Xia Y; Wang S; Xu C; Zhu X; Gao Q
J Cell Mol Med; 2023 Aug; 27(16):2385-2397. PubMed ID: 37386813
[TBL] [Abstract][Full Text] [Related]
2. Hypomethylated gene RAC3 induces cell proliferation and invasion by increasing FASN expression in endometrial cancer.
Meijuan C; Fang L; Min F; Qian W
Int J Biochem Cell Biol; 2022 Sep; 150():106274. PubMed ID: 35917927
[TBL] [Abstract][Full Text] [Related]
3. Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.
Zheng W; Zhang J; Song Q; Xu Y; Zhu M; Ma J
DNA Cell Biol; 2021 Mar; 40(3):469-481. PubMed ID: 33600260
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a prognostic model to predict chemotherapy response and identification of RAC3 as a chemotherapeutic target in bladder cancer.
Chen Y; Huang M; Lu J; Zhang Q; Wu J; Peng S; Chen S; Zhang Y; Cheng L; Lin T; Chen X; Huang J
Environ Toxicol; 2024 Feb; 39(2):509-528. PubMed ID: 37310098
[TBL] [Abstract][Full Text] [Related]
5. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
[No Abstract] [Full Text] [Related]
6. Silencing of Rac3 inhibits proliferation and induces apoptosis of human lung cancer cells.
Liu TQ; Wang GB; Li ZJ; Tong XD; Liu HX
Asian Pac J Cancer Prev; 2015; 16(7):3061-5. PubMed ID: 25854406
[TBL] [Abstract][Full Text] [Related]
7. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
8. Rac3 regulates cell proliferation through cell cycle pathway and predicts prognosis in lung adenocarcinoma.
Wang G; Wang H; Zhang C; Liu T; Li Q; Lin X; Xie J; Liu H
Tumour Biol; 2016 Sep; 37(9):12597-12607. PubMed ID: 27402308
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.
Chen P; Yang Y; Zhang Y; Jiang S; Li X; Wan J
Aging (Albany NY); 2020 Feb; 12(4):3371-3387. PubMed ID: 32074080
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.
Cheng P; Ma J; Zheng X; Zhou C; Chen X
Sci Rep; 2021 Jun; 11(1):12608. PubMed ID: 34131259
[TBL] [Abstract][Full Text] [Related]
11. RAC3 is a pro-migratory co-activator of ERα.
Walker MP; Zhang M; Le TP; Wu P; Lainé M; Greene GL
Oncogene; 2011 Apr; 30(17):1984-94. PubMed ID: 21217774
[TBL] [Abstract][Full Text] [Related]
12. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
Yang Q; Yu B; Sun J
Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
[TBL] [Abstract][Full Text] [Related]
13. Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer.
Shi R; Li H; Wei S; Yu Z; Zhang J; Zhang Q; Zhou T; Yao Y; Zhang Q; Zhang T; Wang H
BMC Cancer; 2023 May; 23(1):491. PubMed ID: 37259038
[TBL] [Abstract][Full Text] [Related]
14. The Rac3 GTPase in Neuronal Development, Neurodevelopmental Disorders, and Cancer.
de Curtis I
Cells; 2019 Sep; 8(9):. PubMed ID: 31514269
[TBL] [Abstract][Full Text] [Related]
15. Single-cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer.
Yu Z; Zhang J; Zhang Q; Wei S; Shi R; Zhao R; An L; Grose R; Feng D; Wang H
Cell Prolif; 2022 Jun; 55(6):e13249. PubMed ID: 35560676
[TBL] [Abstract][Full Text] [Related]
16. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer.
Zhao T; Zhang Y; Ma X; Wei L; Hou Y; Sun R; Jiang J
Cancer Cell Int; 2021 May; 21(1):269. PubMed ID: 34016103
[TBL] [Abstract][Full Text] [Related]
18. Early diagnosis and prognostic potential of RAC3 in bladder tumor.
Wang S; Wei Z; Shu H; Xu Y; Fan Z; Shuang S; Li P; Lu P; Ye C
Int Urol Nephrol; 2024 Feb; 56(2):475-482. PubMed ID: 37728806
[TBL] [Abstract][Full Text] [Related]
19. The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling.
Xu L; Fang Q; Miao Y; Xu M; Wang Y; Sun L; Jia X
Bioengineered; 2021 Dec; 12(1):3467-3484. PubMed ID: 34251980
[TBL] [Abstract][Full Text] [Related]
20. B3GNT3 acts as a carcinogenic factor in endometrial cancer via facilitating cell growth, invasion and migration through regulating RhoA/RAC1 pathway-associated markers.
Wang JS; Ruan F; Guo LZ; Wang FG; Wang FL; An HM
Genes Genomics; 2021 May; 43(5):447-457. PubMed ID: 33683574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
